17th MEET THE PROFESSOR

Advanced International Breast Cancer Course 2021
(AIBCC 2021)

AIBCC 2021 will be held both as an in-class course and as a live webinar!

In-Class Course

30th September 14:30 – 17:30  |  1st October 10.00 – 12:00 & 14:30 – 18:10

ENROLL NOW

LIVE Webinar

30th September 14:45 – 17:30  |  1st October 14:30 – 18:10

ENROLL NOW

Presentation

Objectives of the Course

Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include – besides the “classic” clinical specialties – pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially-responsible clinicians. With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries.

Target Audience of the Course

  • Gynaecologists and obstetrics

  • Medical oncologists

  • Pathologists

  • Radiologists

  • Radiation oncologists

  • Surgeons

  • Biologists

  • Pharmacists

  • Nurses

In-Class Course

30th September 14:30 – 17:30  |  1st October 10.00 – 12:00 & 14:30 – 18:10

ENROLL

The in-class course will take place at the venue specified underneath. Please note that due to COVID mitigation measures, the availability of places for the in-presence course is limited.

The in-class course, with the participation of speakers connected from various countries and local speakers present at the meeting venue, is addressed primarily to Italian participants. The official language of the course is English. No simultaneous translation will be provided.

Please note that AIBCC 2021 can be followed also as a LIVE Webinar

Registration

The standard registration fee is € 180,00. The reduced registration fee for graduate students and nurses is € 100,00.
Online registration is available at this link until 20th September 2021.

Open in Google Maps

Meeting Venue

Four Points by Sheraton, Corso Argentina 5, Padova

Open in Google Maps

Scientific Program

Thursday, September 30th

14:30 Registration of participants
14:45 Introduction to the Conference
Pier Franco Conte, Gabriel N. Hortobagyi, Valentina Guarneri, Philip Poortmans
SESSION I

Chairpersons: Hesham Ahmed Gaballah Elghazaly, Pierfranco Conte

15:00 Obesity and cancer
Roberto Vettor
15:20 Management of women BRCA1/2 and other predisposition gene mutations
Shani Paluch-Shimon
15:40 Axillary dissection: still an option?
Elefterios Mamounas
16:00 Hot topics in breast cancer RT
Philip Poortmans
16:20 Clinical impact of genomics in BC
Aleix Prat
16:40 PIK3CA testing: from technical aspects to clinical application
Sybille Loibl
17:00 Prognostic signatures to guide treatment decision
Gabriel N. Hortobagyi
17:20 Q&A
17:30 Adjourn

Friday, October 1st

SESSION II – MULTIDISCIPLINARY TUMOR BOARD

Chiarperson: Pier Franco Conte, Valentina Guarneri.

10:00 Clinical case 1: omission of RT in elderly patients with low-risk tumor
Franco Berti
10:20 Clinical case 2: cT1c, cN0 HER2+tumor: neo vs adjuvant (option to escalate or de-escalate therapy)
Cristina Falci
10:40 Clinical case 3: post-neoadjuvant therapy in patients with RD (stressing the concept of RCB and characterization of RD)
Federica Miglietta
11:00 Clinical case 4: oligometastatic disease
Grazia Vernaci
11:20 Clinical case 5: brain mets
Gaia Griguolo
11:40 Clinical case: when to stop active therapy
Carlo Alberto Giorgi
12:00 Lunch
SESSION III

Chairpersons: Jacek Jassem, Valentina Guarneri.

14:30 Adjuvant CDK4/6i for HR+ disease: reconciling data from randomized trials
Valentina Guarneri
14:50 Early BRCAm tumors: PARPi are coming!
Pier Franco Conte
15:10 Neoadjuvant therapy for early breast cancer: beyond the pCR dogma
Pier Franco Conte
15:30 Immunotherapy for early TNBC: hopes and hypes
Hope Rugo
15:50 Q&A
16:10 Antibody Drug Conjugates for BC
Frederik Marmè
16:30 Targeting unconventional pathways in Luminal BC
Maria Vittoria Dieci
16:50 Treatment algorithm for HR+/HER2- ABC
Stephen Johnston
17:10 Treatment algorithm for HER2+ ABC
Sandra M. Swain
17:30 Treatment algorithm and new options for TN ABC
Miguel Martin
17:50 Q&A
18:10 Adjourn

CME

This CME activity (31-324769) is worthy: 8 CME points.

The credit certification for the in-class course is subject to the fulfillment of all following conditions:

  • Professions/specializations should correspond to those which have been accredited for CME
  • Attendance no lower than 90% of the meeting
  • Completion of the meeting evaluation online form available at the end of the event (within 3 days from the end of the event)
  • Successful completion of the final questionnaire (completed within 3 days from the end of the event, at least 75% of correct answers,1 attempt admitted)
  • Ownership of an Italian Fiscal Code (Codice Fiscale)

LIVE Webinar

30th September 14:45 – 17:30  |  1st October 14:30 – 18:10

ENROLL

The LIVE Webinar will allow participants to attend to AIBCC 2021 from anywhere in the world.

The LIVE Webinar, with the participation of speakers connected from various countries, is addressed to both Italian and foreign participants. The official language of the course is English. No simultaneous translation will be provided.

To follow the webinar, participants will need a good quality internet connection and a device (PC, Smartphone, Tablet) capable of running a recent Internet browser (e.g. any updated version of Chrome or Firefox).

Registration

The standard registration fee is € 180,00. The reduced registration fee for graduate students and nurses is € 100,00.
Online registration is available at this link until 20th September 2021.

Scientific Program

Thursday, September 30th

14:45 Introduction to the Conference
Pier Franco Conte, Gabriel N. Hortobagyi, Valentina Guarneri, Philip Poortmans
SESSION I

Chairpersons: Hesham Ahmed Gaballah Elghazaly, Pierfranco Conte.

15:00 Obesity and cancer
Roberto Vettor
15:20 Management of women BRCA1/2 and other predisposition gene mutations
Shani Paluch-Shimon
15:40 Axillary dissection: still an option?
Elefterios Mamounas
16:00 Hot topics in breast cancer RT
Philip Poortmans
16:20 Clinical impact of genomics in BC
Aleix Prat
16:40 PIK3CA testing: from technical aspects to clinical application
Sybille Loibl
17:00 Prognostic signatures to guide treatment decision
Gabriel N. Hortobagyi
17:20 Q&A
17:30 Adjourn

Friday, October 1st

SESSION II

Chairpersons: Jacek Jassem, Valentina Guarneri.

14:30 Adjuvant CDK4/6i for HR+ disease: reconciling data from randomized trials
Valentina Guarneri
14:50 Early BRCAm tumors: PARPi are coming!
Pier Franco Conte
15:10 Neoadjuvant therapy for early breast cancer: beyond the pCR dogma
Pier Franco Conte
15:30 Immunotherapy for early TNBC: hopes and hypes
Hope Rugo
15:50 Q&A
16:10 Antibody Drug Conjugates for BC
Frederik Marmè
16:30 Targeting unconventional pathways in Luminal BC
Maria Vittoria Dieci
16:50 Treatment algorithm for HR+/HER2- ABC
Stephen Johnston
17:10 Treatment algorithm for HER2+ ABC
Sandra M. Swain
17:30 Treatment algorithm and new options for TN ABC
Miguel Martin
17:50 Q&A
18:10 Adjourn

CME

This CME activity (31-324301) is worthy: 9 CME points.

The credit certification for the webinar is subject to the fulfillment of all following conditions:

  • Professions/specializations should correspond to those which have been accredited for CME
  • Attendance no lower than 100% of the webinar
  • Completion of the meeting evaluation online form available at the end of the event (within 3 days from the end of the event)
  • Successful completion of the final questionnaire (completed within 3 days from the end of the event, at least 75% of correct answers,5 attempts admitted)
  • Ownership of an Italian Fiscal Code (Codice Fiscale)

Faculty

Directors

Pierfranco Conte
Pierfranco ContePadova (I)
Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
Valentina Guarneri
Valentina GuarneriPadova (I)
Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
Gabriel N. Hortobagyi
Gabriel N. HortobagyiHouston (USA)
Department of Breast Medical Oncology
The University of Texas – MD Anderson Cancer Center
Philip Poortmans
Philip PoortmansWilrijk-Antwerp (B)
Former president of ESTRO and of ECCO
Department of Radiation Oncology
Iridium Netwerk
University of Antwerp

Scientific Commitee

Hesham Ahmed Gaballah Elghazaly
Cairo (EG)

Jacek Jassem
Gdansk (PL)

Stephen Johnston
London (UK)

Sibylle Loibl
Frankfurt (D)

Eleuterios Mamounas
Orlando (USA)

Miguel Martin
Madrid (E)

Stefania Migliuolo
Milano (I)

Fedro Alessandro Peccatori
Milano (I)

Aleix Prat
Barcellona (E)

Sandra M. Swain
Washington (USA)

Speakers

Franco Berti
Padova (I)

Pierfranco Conte
Padova (I)

Maria Vittoria Dieci
Padova (I)

Cristina Falci
Padova (I)

Carlo Alberto Giorgi
Padova (I)

Gaia Griguolo
Padova (I)

Gabriel N. Hortobagyi
Houston (USA)

Jacek Jassem
Gdansk(PL)

Stephen Johnston
London (UK)

Sibylle Loibl
Frankfurt (D)

Eleuterios Mamounas
Orlando (USA)

Frederik Marmè
Heidelberg (DE)

Miguel Martin
Madrid (E)

Federica Miglietta
Padova (I)

Shani Paluch-Shimon
Jerusalem (IL)

Philip Poortmans
Wilrijk-Antwerp (B)

Aleix Prat
Barcellona (E)

Hope Rugo
San Francisco (USA)

Sandra M. Swain
Washington (USA)

Grazia Vernaci
Padova (I)

Roberto Vettor
Padova (I)

Under the Patronage

ISTITUTIONS

SCIENTIFIC SOCIETIES